Application 211361
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
| 002 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 1GM | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211361-001 | RANOLAZINE | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | |
| A211361-002 | RANOLAZINE | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211361-001 | AB |
| A211361-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211361-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211361-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211361-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211361-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211361-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211361-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211361-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211361-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-04-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211361-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211361-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211361-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211361-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211361-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211361-002 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211361-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211361-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ranolazine | RANOLAZINE | Major Pharmaceuticals | 6166c40c-4fbe-47c4-92e4-2dc5d3567a86 | 2026-06-09 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Lifestar Pharma LLC | 195c4b51-fec2-410d-8d90-487c536a8728 | 2026-05-06 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Zameer Pharmaceuticals LLC | 5f4fc8a4-2bd5-4378-8882-e739c951390e | 2026-04-21 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Torrent Pharma, Inc. | d2454377-2abd-4d9f-85f1-12f1adbb10e5 | 2026-04-15 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | SunGen Pharma LLC | f3c09979-a44a-4197-97d2-29a207b6fc73 | 2026-03-25 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| RANOLAZINE | RANOLAZINE | Radha Pharmaceuticals, Inc | 38d2833d-44b8-8d46-e063-6394a90a74d8 | 2026-02-20 | Warnings, Adverse reactions | RANOLAZINE RANOLAZINE |
| Ranolazine | RANOLAZINE | Zydus Lifesciences Limited | d74f3dea-7357-4e9a-be9a-2f498a44108a | 2026-01-29 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Viona Pharmaceuticals Inc | 00979fb3-d70f-493d-94ca-2914cbadaa9d | 2026-01-29 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | 0cf58732-c242-49b0-8e3f-248778b4458d | 2026-01-23 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | NCS HealthCare of KY, LLC dba Vangard Labs | 2373687b-b9a4-496e-b89f-9754f8513fd3 | 2026-01-21 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | AvKARE | b2a8dc3e-a880-5241-e053-2995a90a933a | 2026-01-15 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | AvPAK | e92350e8-5b0b-95d3-e053-2995a90a959b | 2026-01-09 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| RANOLAZINE | RANOLAZINE | Aphena Pharma Solutions - Tennessee, LLC | 45236b7d-3728-1e13-e063-6394a90ad77f | 2025-12-04 | Warnings, Adverse reactions | RANOLAZINE RANOLAZINE |
| Ranolazine | RANOLAZINE | Ajanta Pharma USA Inc. | 8bfd1a61-547a-4847-ae4e-480b17da6272 | 2025-10-28 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| Ranolazine | RANOLAZINE | Ascend Laboratories, LLC | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 2025-07-28 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| RANOLAZINE | RANOLAZINE | A2A Integrated Pharmaceuticals | 9fb62878-c76a-4be2-99be-962ce2956af2 | 2025-02-28 | Warnings, Adverse reactions | RANOLAZINE RANOLAZINE |
| ASPRUZYO SPRINKLE | RANOLAZINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | dd9f81e4-50da-4551-aed5-559d304df42e | 2025-01-29 | Warnings, Adverse reactions | RANOLAZINE |
| RANOLAZINE | RANOLAZINE | Bryant Ranch Prepack | 9199e28a-ddbe-46a4-ab26-9b08034289be | 2025-01-23 | Warnings, Adverse reactions | RANOLAZINE RANOLAZINE |
| Ranolazine | RANOLAZINE | Bryant Ranch Prepack | 2e678c80-1410-433b-8c48-4b210eceb0de | 2025-01-17 | Warnings, Adverse reactions | Ranolazine RANOLAZINE |
| RANOLAZINE | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 71d50258-75b7-4801-b0f4-c34fe883d57d | 2024-12-24 | Warnings, Adverse reactions | RANOLAZINE RANOLAZINE |